When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADAP - Adaptimmune up 24% premarket on T-cell therapy development deal
Adaptimmune Therapeutics plc
Adaptimmune Therapeutics (NASDAQ:ADAP) inks an agreement with Astellas Pharma (OTCPK:ALPMF) aimed at co-developing and co-commercializing up to three T-cell therapies in cancer.
More news on: Adaptimmune Therapeutics plc, Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news, Stocks on the move,